A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.
Amelung
While patients with chronic diseases know that medication is critical to their treatment and health, they don’t always act on that knowledge, according to a new survey.
“Knowing But Not Doing: The State of Rx Adherence in America Report,” from Express Scripts, found that nearly one-third of those taking prescription medications for chronic conditions say they are not concerned about forgetting to take their medications despite the fact that almost one-half believe it is the most important thing they can do to protect their health. They also don’t want to be nagged by their spouse/partner about taking their medicine, rating them as the most annoying source of reminders to take their medicine.
“Given the huge cost of nonadherence to an individual patient’s health, as well as to the country as a whole, it’s essential for patients and clinicians to work together to find solutions to help overcome barriers to adherence,” says Kyle Amelung, PharmD, BCPS, is a senior clinical consultant on Express Scripts’ clinical solutions team.
The survey was conducted by Russell Research on behalf of Express Scripts between February 14 to 22, 2018, among 800 adults (18 years and older) taking medications to treat any of the following chronic diseases:
Other unique findings
The survey also found:
“Based on the results of this survey, it’s clear that technology-enabled tools, that also offer rewards and other incentives, can help patients with chronic health conditions remain more adherent with their therapy,” says Amelung.
Advanced technology aids in adherence
Express Scripts, in partnership with Mango Health, to create a customized mobile health platform designed to generate patient engagement, retention, and adherence through the use of an individualized smartphone app.
Express Scripts also partners with Propeller Health to provide members access to inhaler sensors and a mobile app to manage asthma or COPD, and Livongo and Lifescan for diabetes remote monitoring.
“In addition, Express Scripts has a proprietary adherence solution that uses predictive modeling to identify patients at risk of nonadherence with as much as 94% accuracy. Once identified, ScreenRx activates personalized interventions to help patients stay on their therapy and improve health outcomes,” Amelung says.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More